Emma Watson invests in reproductive health company Hertility

Emma Watson invests in women's health startup Hertility focused on reproductive care.

: Emma Watson has invested in Hertility, a women's health company, increasing its funding to $14 million. Hertility, co-founded by Dr. Helen O’Neill and Dr. Natalie Getreu, aims to innovate reproductive healthcare with services like diagnostic testing and telemedicine. The investment supports the growth of women-led initiatives in the U.K. amidst a healthcare gap highlighted by studies.

Emma Watson, known for advocating women's rights, has invested in Hertility, a women's health company, elevating its funding beyond $14 million. Dr. Helen O’Neill, CEO and co-founder of Hertility, met Watson through an investor who recognized Watson's alignment with women's rights, catalyzing this investment.

Hertility, founded by O'Neill along with Dr. Natalie Getreu and Deirdre O’Neill, aims to transform reproductive healthcare by offering personalized testing, diagnostic services, egg freezing, and telemedicine. Based in the U.K., Hertility highlights considerable delays in healthcare access for women, as evidenced by the 600,000 women waiting for gynecology appointments.

The need for innovative women's healthcare solutions has spurred venture capital interest, as seen in the 314% rise in funding for women's health companies. Beyond investment, Hertility collaborates with brands like Cult Beauty and offers educational sessions to organizations such as Channel 4, aiming to empower women globally in understanding their reproductive health.

Reproductive HealthWomens HealthHertility